Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.200 -0.070 (-5.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Bionano’s Technology Is Interesting, But Its Earnings Are Uninspiring ↗
Bionano could become a decent testing company within its niche. However, BNGO stock has run far ahead of the company's fundamentals. 
Via InvestorPlace
News headline image
AMC Entertainment Tops Q2 Trends For Millenials And Gen Z, WISH Enters The Top 100 ↗
A quarterly report from Apex Clearing shows what the top owned stocks are among Millenials and Gen Z. Here is a look at the top holdings and the biggest movers from the first... 
Via Benzinga
News headline image
Weak Fundamentals Prove There Is No Reason to Buy Bionano Genomics ↗
Bionano Genomics is risky and its valuation does not justify its price. There is no compelling argument for a buy in BNGO stock. 
Via InvestorPlace
News headline image
You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush ↗
With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip. 
Via InvestorPlace
News headline image
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
News headline image
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week ↗
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news. 
Via The Motley Fool
News headline image
Unusual Options Activity Insight: Bionano Genomics ↗
Bionano Genomics (NASDAQ:BNGO) shares experienced unusual options activity on Friday. The stock price moved up to $6.71 following the option alert. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
Cramer Gives His Opinion On RadNet, Nano Dimension And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said RadNet Inc. (NASDAQ: RDNT) is a great situation and he likes the stock. BioNano Genomics Inc (NASDAQ: BNGO) is... 
Via Benzinga
News headline image
Understanding Bionano Genomics's Unusual Options Activity ↗
Shares of Bionano Genomics (NASDAQ:BNGO) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $7.05. Sentiment:... 
Via Benzinga
News headline image
Bionano Genomics Stock Has Short-Term Opportunities ↗
BNGO stock has established a reliable trading range. Even long-term investors can game it while they wait for their long-term reward. 
Via InvestorPlace
News headline image
BNGO Stock: 2 Big Reasons Bionano Genomics Fans Should Be Cheering ↗
Bionano Genomics (BNGO) stock is getting a boost on Monday from a couple of new pieces of news that traders will want to know. 
Via InvestorPlace
News headline image
44 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
Via Benzinga
News headline image
Wait for the Reddit Set to Sell Before Buying Bionano Stock ↗
Genomics play BNGO stock may pay off down the road, but wait for a meme stock investor exodus before making it a buy 
Via InvestorPlace
News headline image
Why Bionano Genomics Stock Is Trading Higher Today ↗
BioNano Genomics Inc (NASDAQ: BNGO) shares are trading higher by 3.7% at $7.80 Monday morning after the company announced that it was added as a member of the U.S. small... 
Via Benzinga
News headline image
Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks ↗
Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics. 
Via InvestorPlace
News headline image
Don’t Wait Around for a Short Squeeze on Bionano Genomics Stock ↗
There are viable short-squeeze arguments available but BNGO stock is probably not one of them. 
Via InvestorPlace
News headline image
Geographic Expansion Enables Healthy Diagnosis for Bionano Genomics ↗
BNGO stock has a clear shot at revisiting its all-time high price 
Via InvestorPlace
News headline image
The Owners of Bionano Stock Will Be Hurt by Dilution ↗
BNGO stock looks decent until you dive deeper and understand what's really going on. The shares' outlook isn't good. 
Via InvestorPlace
News headline image
Bionano Genomics: Did Reddit Squirrels Find a Nut? ↗
BNGO stock has been pushed this year by both Wall Street pros and meme stock amateurs. Its optical genetic sequencing technique could make it a winner. 
Via InvestorPlace
News headline image
Analyst Says Bionano Genomics Has 26% Upside: Should You Buy? ↗
Before you buy some BNGO stock, you might want to check out some of the competition 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021 ↗
Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Aytu BioPharma (NASDAQ:AYTU) stock increased by 19.36% to $6.41 during Tuesday's pre-market session. The market value of their outstanding shares is at $161.3... 
Via Benzinga
News headline image
Is It Too Late to Buy BioNano Genomics Stock? ↗
Does this gene-testing biotech company have value as more than a short-squeeze play? 
Via The Motley Fool
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
News headline image
Why Bionano Genomics Stock Soared Today ↗
The genetic testing specialist is bolstering its leadership ranks. 
Via The Motley Fool
News headline image
Dow, S&P Erase Gains at Midday Despite Strong Start ↗
The Dow Jones Industrial Average is down roughly 124 points at midday, erasing this morning's gains despite nearing a fresh intraday high earlier in the session. 
Via Talk Markets
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Atossa Therapeutics (NASDAQ:ATOS)... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) surged 60.3% to $5.93 after the company... 
Via Benzinga
News headline image
Bionano Runs Higher Following CCO Appointment ↗
Bionano Genomics Inc. (NASDAQ: BNGO) shares climbed higher Monday after the company appointed Jason Priar as its Chief Commercial Officer. Priar was formerly a sales leader at... 
Via Benzinga
News headline image
Unusual Options Activity Insight: Bionano Genomics ↗
On Monday, shares of Bionano Genomics (NASDAQ:BNGO) saw unusual options activity. After the option alert, the stock price moved up to $8.23. Sentiment: BEARISH Option Type:... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.